Company intelligence / Profile preview

Progress Therapeutics Inc.

Ownership: Private
Development stage: Phase 2

Overview

Progress Therapeutics specializes in importing and facilitating the market entry of a wide range of healthcare products—including OTC and prescription drugs, vaccines, biologics, APIs, medical devices, natural health products, and investigational medicinal products—into Canada. The company provides regulatory guidance for licensing requirements to help clients bring their healthcare offerings to the Canadian market efficiently.[1]

Modalities: Over-the-Counter (OTC) drugsPrescription drugsVaccinesBiologicsActive Pharmaceutical Ingredients (APIs)Medical devicesNatural health productsInvestigational medicinal products[1]
Industry: Consulting

Drug pipeline

2 assets

LYT-100

Phase 2

Indications: Idiopathic pulmonary fibrosis

1 more asset in the full pipeline.

Request access →

Beyond the preview

Go deeper on Progress Therapeutics Inc..

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Progress Therapeutics Inc..

Explore the full profile